[1] MARINA A. DOBROVOLSKAIA*. Nanoparticle Size and Surface Charge Determine Effects of PAMAM Dendrimers on Human Platelets in Vitro[J]. Molecular Pharmaceutics, 2011, 9 3: 382-393. DOI:
10.1021/mp200463e[2] PHILIP FÖRSTNER. Cationic PAMAM Dendrimers as Pore-Blocking Binary Toxin Inhibitors[J]. Biomacromolecules, 2014, 15 7: 2461-2474. DOI:
10.1021/bm500328v[3] ESTEBAN N. GURZOV. Inhibition of hIAPP Amyloid Aggregation and Pancreatic β-Cell Toxicity by OH-Terminated PAMAM Dendrimer[J]. Small, 2016, 12 12: 1615-1626. DOI:
10.1002/smll.201502317[4] BURÇIN YAVUZ. In Vitro/In Vivo Evaluation of Dexamethasone—PAMAM Dendrimer Complexes for Retinal Drug Delivery[J]. Journal of pharmaceutical sciences, 2015, 104 11: Pages 3814-3823. DOI:
10.1002/jps.24588[5] ROSARIO PLANELLÓ . Genotoxic effects and transcriptional deregulation of genetic biomarkers in Chironomus riparius larvae exposed to hydroxyl- and amine-terminated generation 3 (G3) polyamidoamine (PAMAM) dendrimers[J]. Science of the Total Environment, 2021, 774: Article 145828. DOI:
10.1016/j.scitotenv.2021.145828